After a detailed assessment of the technical documentation of 9 different mesh implants intended to treat pelvic organ prolapse used in NL (2018) RIVM concludes that the safety and performance of these products were not properly substantiated.

In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.

Synthetic mesh are used to treat patients with pelvic organ prolapse. There are two surgical routes that can be used to implant mesh: transvaginal and transabdominal.

On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.